These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21765834)

  • 1. Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.
    Woolery KT; Kruk PA
    Obstet Gynecol Int; 2011; 2011():358493. PubMed ID: 21765834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omentum-on-a-chip: A multicellular, vascularized microfluidic model of the human peritoneum for the study of ovarian cancer metastases.
    Ibrahim LI; Hajal C; Offeddu GS; Gillrie MR; Kamm RD
    Biomaterials; 2022 Sep; 288():121728. PubMed ID: 35995621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
    Li J; Qin X; Shi J; Wang X; Li T; Xu M; Chen X; Zhao Y; Han J; Piao Y; Zhang W; Qu P; Wang L; Xiang R; Shi Y
    Elife; 2021 Jun; 10():. PubMed ID: 34114949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.
    Yeung TL; Leung CS; Yip KP; Au Yeung CL; Wong ST; Mok SC
    Am J Physiol Cell Physiol; 2015 Oct; 309(7):C444-56. PubMed ID: 26224579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity.
    Miyamoto T; Murphy B; Zhang N
    Front Immunol; 2023; 14():1104694. PubMed ID: 37180125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.
    Yousefi M; Dehghani S; Nosrati R; Ghanei M; Salmaninejad A; Rajaie S; Hasanzadeh M; Pasdar A
    Cell Oncol (Dordr); 2020 Aug; 43(4):515-538. PubMed ID: 32418122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
    Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
    Anticancer Agents Med Chem; 2017; 17(8):1093-1101. PubMed ID: 28002999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer stroma: pathophysiology and the roles in cancer development.
    Furuya M
    Cancers (Basel); 2012 Jul; 4(3):701-24. PubMed ID: 24213462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Intra-peritoneal Ovarian Cancer Metastasis.
    Lewellen KA; Metzinger MN; Liu Y; Stack MS
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Motohara T; Masuda K; Morotti M; Zheng Y; El-Sahhar S; Chong KY; Wietek N; Alsaadi A; Carrami EM; Hu Z; Artibani M; Gonzalez LS; Katabuchi H; Saya H; Ahmed AA
    Oncogene; 2019 Apr; 38(16):2885-2898. PubMed ID: 30568223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis.
    Li M; Wang J; Wang C; Xia L; Xu J; Xie X; Lu W
    Exp Cell Res; 2020 Sep; 394(1):112153. PubMed ID: 32589888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma.
    Barbolina MV
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30445726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
    Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
    BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for targeting the ovarian tumor stroma.
    Ko SY; Naora H
    World J Clin Cases; 2014 Jun; 2(6):194-200. PubMed ID: 24945005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression.
    Lawrenson K; Grun B; Gayther SA
    J Vis Exp; 2012 Aug; (66):e4206. PubMed ID: 22951414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites Volumes and the Ovarian Cancer Microenvironment.
    Penet MF; Krishnamachary B; Wildes FB; Mironchik Y; Hung CF; Wu TC; Bhujwalla ZM
    Front Oncol; 2018; 8():595. PubMed ID: 30619738
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.